Mankind Pharma Q1 Results: PAT soars 66% YoY to Rs 487 crore on strong all-round show

August 2, 2023

Operating profit, calculated as earnings before interest, taxes, depreciation and amortisation (EBITDA) for the quarter surged 43% YoY to Rs 660 crore, with margins expanding by a staggering 450 basis points to 25.6%.

More To Explore

Trump will claim victory in the next couple of weeks and then reverse the policies he has introduced: Ramesh Damani

Ramesh Damani believes Donald Trump will reverse his policies and declare victory to avoid admitting failure. He argues Trump’s actions are damaging global order and

April 3, 2025

Small & midcaps in a time correction phase, recovery expected in FY26: Trideep Bhattacharya

India’s competitive advantage is improving due to cooling dollar and oil prices, with tariffs on China benefiting India. Sectors like financials, real estate, and building

April 3, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003